SCHEMBL22736319

SCHEMBL22736319

C[S+]([O-])CCC(C#N)c1ccc(-n2cc(-c3ccnc(N)c3[N+](=O)[O-])cn2)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29480651 0.88 — —
SCHEMBL22735766 0.79 GRM4 (0.31) —
SCHEMBL22735769 0.78 EGLN1 (0.33) —
SCHEMBL22735954 0.78 EGLN1 (0.34) —
SCHEMBL29480652 0.78 EGLN1 (0.34) —
SCHEMBL29480668 0.77 EGLN1 (0.38) —
SCHEMBL22736533 0.77 EGLN1 (0.38) —
SCHEMBL29480720 0.77 EGLN1 (0.37) —
SCHEMBL22736126 0.77 EGLN1 (0.37) —
SCHEMBL29567604 0.76 RPS6KB1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020240586-A1 NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 MANKIND PHARMA LTD. (IN) 2020-12-03 — — WO disclosed
Send feedback